At the epithelial level, new entities defined by genetic aberrations have emerged, such as SMARCB1-deficient renal medullary carcinoma, TFEB-mutated RCC, ELOC-mutated RCC and ALK-rearranged RCC. This evidence concerns the gene SMARCB1 and renal cell carcinoma.